(Reuters) - The company had filed a New Drug Application for the treatment in July last year after completing a late-stage trial in the fourth quarter of 2005.
Read more at Reuters.com Government Filings News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment